clinical trial · NCT05017935
RADIANCE Continued Access Protocol
ReCor Medical, Inc.·N/A·active not recruiting·n = 300
HypertensionHypertension, Resistant to Conventional TherapyVascular DiseasesCardiovascular DiseasesRenal Denervation
brief summary
RADIANCE CAP is a non-randomized study designed to allow for continued access to ultrasound renal denervation therapy via the Paradise System, and to allow for the on-going collection of safety and effectiveness data in subjects with uncontrolled hypertension despite the prescription of antihypertensive medications.
started
May 4, 2022
primary completion
Dec 31, 2028
completion
Dec 31, 2028
last updated
Jun 17, 2024
official title
RADIANCE Continued Access Protocol (RADIANCE CAP): A Study of the ReCor Medical Paradise System in Clinical Hypertension
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol